|
KLRA Kailera Therapeutics Inc 2096997 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-111,307,000.00 |
| Balance Sheet |
|
Current Assets
|
$929,167,000.00 |
|
Assets
|
$1,211,416,000.00 |
|
Current Liabilities
|
$83,651,000.00 |
|
Liabilities
|
$92,952,000.00 |
|
Equity
|
$1,118,464,000.00 |
|
Shares Out
|
129620370.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-145,837,000.00 |
|
Investing Cash Flow
|
$-548,175,000.00 |
| Market Analysis |
Market Cap
|
$2,263,171,660.20 |
|
Price
|
$17.46 |
|
BVPS
|
8.63 |
|
PB
|
2.02 |
|
EPS
|
-1.09 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:19 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KLRA documents filed with the SEC.
KLRA Filings
Clear
